Brentuximab Vedotin effects on prognosis of refractory and relapsed peripheral T-Cell lymphoma: a systematic review. Rev Med Saude Brasilia. 2019;7(2). Accessed September 23, 2026. https://portalrevistas.ucb.br/index.php/rmsbr/article/view/9251